Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,458 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Repeated courses of rituximab in chronic ITP: Three different regimens.
Hasan A, Michel M, Patel V, Stasi R, Cunningham-Rundles S, Leonard JP, Bussel J. Hasan A, et al. Among authors: michel m. Am J Hematol. 2009 Oct;84(10):661-5. doi: 10.1002/ajh.21512. Am J Hematol. 2009. PMID: 19731307 Free PMC article. Clinical Trial.
Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use program.
Khellaf M, Michel M, Quittet P, Viallard JF, Alexis M, Roudot-Thoraval F, Cheze S, Durand JM, Lefrère F, Galicier L, Lambotte O, Panelatti G, Slama B, Damaj G, Sebahoun G, Gyan E, Delbrel X, Dhedin N, Royer B, Schleinitz N, Rossi JF, Mahévas M, Languille L, Bierling P, Godeau B. Khellaf M, et al. Among authors: michel m. Blood. 2011 Oct 20;118(16):4338-45. doi: 10.1182/blood-2011-03-340166. Epub 2011 Aug 10. Blood. 2011. PMID: 21832276 Free article. Clinical Trial.
Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients.
Gobert D, Bussel JB, Cunningham-Rundles C, Galicier L, Dechartres A, Berezne A, Bonnotte B, DeRevel T, Auzary C, Jaussaud R, Larroche C, LeQuellec A, Ruivard M, Seve P, Smail A, Viallard JF, Godeau B, Hermine O, Michel M. Gobert D, et al. Among authors: michel m. Br J Haematol. 2011 Nov;155(4):498-508. doi: 10.1111/j.1365-2141.2011.08880.x. Epub 2011 Oct 8. Br J Haematol. 2011. PMID: 21981575 Free PMC article.
A case-control study to assess the risk of immune thrombocytopenia associated with vaccines.
Grimaldi-Bensouda L, Michel M, Aubrun E, Leighton P, Viallard JF, Adoue D, Magy-Bertrand N, Tisserand G, Khellaf M, Durand JM, Quittet P, Fain O, Bonnotte B, Morin AS, Limal N, Costedoat-Chalumeau N, Morel N, Pan-Petesch B, Decaux O, Mahevas M, Ruel M, Sacre K, Lefrere F, Abenhaim L, Godeau B; PGRx Immune Thrombocytopenia Study Group. Grimaldi-Bensouda L, et al. Among authors: michel m. Blood. 2012 Dec 13;120(25):4938-44. doi: 10.1182/blood-2012-05-431098. Epub 2012 Oct 24. Blood. 2012. PMID: 23100310 Free article. Clinical Trial.
Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group.
Rodeghiero F, Michel M, Gernsheimer T, Ruggeri M, Blanchette V, Bussel JB, Cines DB, Cooper N, Godeau B, Greinacher A, Imbach P, Khellaf M, Klaassen RJ, Kühne T, Liebman H, Mazzucconi MG, Newland A, Pabinger I, Tosetto A, Stasi R. Rodeghiero F, et al. Among authors: michel m. Blood. 2013 Apr 4;121(14):2596-606. doi: 10.1182/blood-2012-07-442392. Epub 2013 Jan 29. Blood. 2013. PMID: 23361904 Free article.
A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopenia.
Khellaf M, Viallard JF, Hamidou M, Cheze S, Roudot-Thoraval F, Lefrere F, Fain O, Audia S, Abgrall JF, Michot JM, Dauriac C, Lefort S, Gyan E, Niault M, Durand JM, Languille L, Boutboul D, Bierling P, Michel M, Godeau B. Khellaf M, et al. Among authors: michel m. Haematologica. 2013 Jun;98(6):881-7. doi: 10.3324/haematol.2012.074633. Epub 2013 Feb 26. Haematologica. 2013. PMID: 23445876 Free PMC article.
2,458 results